Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
2.440
+0.070 (2.95%)
Oct 26, 2026, 11:08 AM EDT - Market open
Apyx Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 58.42 | 52.84 | 48.1 | 52.35 | 44.51 | 48.52 |
Revenue Growth | 25.59% | 9.86% | -8.11% | 17.61% | -8.26% | 75.08% |
Gross Profit Gross Profit Growth | 37.09 | 33.04 | 29.36 | 33.76 | 29.13 | 33.6 |
Operating Income Operating Income Growth | -3.54 | -6.45 | -18.85 | -19.95 | -23.31 | -14.45 |
Net Income Net Income Growth | -8.63 | -11.21 | -23.46 | -18.71 | -23.18 | -15.17 |
Earnings Per Share EPS Growth | -0.20 | -0.27 | -0.66 | -0.54 | -0.67 | -0.44 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Surgical Aesthetics Surgical Aesthetics Growth | 50.9 | 45.33 | 38.61 | 43.38 | 36.8 | 42.99 |
Original Equipment Manufacturing (OEM) Original Equipment Manufacturing (OEM) Growth | 7.52 | 7.51 | 9.5 | 8.97 | 7.71 | 5.53 |
Total Total Growth | 58.42 | 52.84 | 48.1 | 52.35 | 44.51 | 48.52 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 27.62 | 31.74 | 31.74 | 43.65 | 10.19 | 30.87 |
Total Debt Total Debt Growth | 39.63 | 39.34 | 38.76 | 38.5 | 0.8 | 0.31 |
Net Cash (Debt) Net Cash Growth | -12.01 | -7.6 | -7.02 | 5.15 | 9.4 | 30.57 |
Net Cash Growth | - | - | - | -45.18% | -69.26% | -25.88% |
Net Cash Per Share Net Cash Per Share Growth | -0.28 | -0.18 | -0.20 | 0.15 | 0.27 | 0.89 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -10.13 | -8 | -18.05 | -5.25 | -20.28 | -10.45 |
Capital Expenditures CapEx Growth | -0.92 | -1.11 | -0.72 | -0.53 | -1.01 | -0.72 |
Free Cash Flow Free Cash Flow Growth | -11.05 | -9.12 | -18.77 | -5.78 | -21.29 | -11.17 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.50% | 62.53% | 61.04% | 64.49% | 65.45% | 69.26% |
Operating Margin | -6.06% | -12.20% | -39.18% | -38.11% | -52.38% | -29.78% |
Pretax Margin | -13.65% | -20.50% | -48.45% | -40.65% | -51.47% | -30.55% |
Profit Margin | -14.78% | -21.21% | -48.78% | -35.75% | -52.09% | -31.27% |
FCF Margin | -18.91% | -17.25% | -39.02% | -11.04% | -47.83% | -23.03% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 267.00 | 267.00 | 267.00 | 267.00 | 267.00 |
PS Ratio | 1.71 | 2.72 | 1.24 | 1.73 | 1.82 | 9.07 |